CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,953 enrolled
Drug / intervention
Patient-reported questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04890314
NCT04890314N/ACompleted
CompareCT.gov

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

Weill Medical College of Cornell University·observational·Posted May 18, 2021·Updated May 22, 2025

In Brief

An observational study evaluating Patient-reported questionnaire for Prostate Cancer. Completed, enrolled 1,953 participants across 4 sites.

Detailed Summary

This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, such as general health, urinary, sexual, and bowel function, cancer anxiety, and treatment regret will be compared and tracked over the course of this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 18, 2021
Enrollment StartMay 15, 2021
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.1 years ago

Interventions

Patient-reported questionnaireother

Validated questionnaires administered at baseline, 8 months following treatment, and 12 months following treatment.